رمز بسيط، تكوّن من سلسلة روابط مُحاطة بدائرة، وهي رمز شائع للاتصال أو الارتباط التشعبي. تم تحديد خطوط الأيقونة بلون أسود داكن على الخلفية، مع إضافة عناصر عسكرية من الهوية الوطنية السعودية مثل الغترة والشماع والبشت السعودي، لتعكس الطابعة المحلية المميزة لجامعة القصيم.

روابط المواقع الالكترونية الرسمية التعليمية السعودية تنتهي بـ

edu.sa

جميع روابط المواقع الرسمية التعليمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .edu.sa

علامة لفتة سوداء اللون من الجلد البسيط، قبضة بدائرة سوداء، يعلوها رسم واضحي لغترة سعودية مع شماع وعقال، تبرز معالم البشت السعودي في. يرمز هذا التصميم إلى مفهوم الأمان وخصوصية البيانات الرقمية يعكس هوية جامعة القصيم.
المواقع الالكترونية الحكومية تستخدم بروتوكول HTTPS للتشفير و الأمان.
المواقع الالكترونية الآمنة في المملكة العربية السعودية تستخدم بروتوكول HTTPS للتشفير.
هيئة الحكومة الرقمية

أعضاء هيئة التدريس

المحتوى

يرتدي رجل يرتدي زيًا أبيض تقليديًا مع شماغ سعودي أحمر وأبيض داخل أحد المباني، مسجون في الكاميرا بتعبير حيادي كما لو كان يلتقط صورة لملف أعضاء هيئة التدريس في جامعة القصيم.
صورة عضو هيئة التدريس

اسامه محمد عبدالرحمن الفايز

أستاذ مشارك
كلية الصيدلة،
قسم ممارسة الصيدلة

البيانات الشخصية

    المؤهلات العلمية

      الاهتمامات البحثية

        الأبحاث المنشورة

        • Clinical Characteristics and Outcomes of Deep Vein Thrombosis in Relation to Location: A Retrospective Analysis Study (2025-01-01)
        • Economic evaluation of brivaracetam in the adjunctive treatment of patients with focal-onset seizure in Jordan (2025-10-31)
        • Stress ulcer prophylaxis in non-critically ill patients: A cross-sectional survey in Saudi Arabia (2025-11-28)
        • Precipitating Factors, Complications, and Outcomes of Diabetic Ketoacidosis (DKA) in Adults and Pediatrics: A Descriptive Study from Two Tertiary Centers in Riyadh, Saudi Arabia (2025-11-30)
        • Safety and Effectiveness of Direct Oral Anticoagulants Versus Warfarin in Patients with Venous Thromboembolism using Real-World Data: A Systematic Review and Meta-Analysis (2024-09-10)
        • Safety and effectiveness of thromboprophylaxis use in hospitalized elderly medical patients at a Saudi tertiary care center (2021-05-31)
        • Economic analysis of glucagon like peptide-1 receptor agonists from the Saudi Arabia payer perspective (2022-04-27)
        • Types, trends, and patterns of the reported antimicrobial errors to the eastern region's medical centers in Saudi Arabia: A cross-sectional study (2023-03-31)
        • Metformin use among obese patients with prediabetes in Qassim, Saudi Arabia: An observational study (2023-07-24)
        • Appropriateness of proton pump inhibitors use in noncritically ill hospitalized children in a tertiary hospital in Saudi Arabia (2023-08-09)
        • Current situation and barriers to women's leadership in health care education in Saudi Arabia: A cross-sectional study (2024-03-19)
        • Association between oral loop diuretics duration before discharge and hospital readmission in acute decompensated heart failure: A multicenter retrospective cohort study (2024-12-06)
        • Safety and efficacy of dual versus triple antithrombotic therapy (DAT vs TAT) in patients with atrial fibrillation following a PCI: a systematic review and network meta-analysis (2020-01-01)
        • Indirect comparison of glucagon like peptide-1 receptor agonists regarding cardiovascular safety and mortality in patients with type 2 diabetes mellitus: network meta-analysis (2020-06-22)
        • The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancer-associated venous thromboembolism: a meta-analysis and review of the guidelines (2021-10-30)
        • Incidence of Diabetic Ketoacidosis Among Pediatrics With Type 1 Diabetes Prior to and During COVID-19 Pandemic: A Meta-Analysis of Observational Studies (2022-03-09)
        • Parents' Hesitancy to Vaccinate Their 5-11-Year-Old Children Against COVID-19 in Saudi Arabia: Predictors From the Health Belief Model (2022-03-30)
        • Parents' Hesitancy to Vaccinate Their 5-11-Year-Old Children Against COVID-19 in Saudi Arabia: Predictors From the Health Belief Model (vol 10, 842862, 2022) (2022-06-01)
        • The use of metformin for type 2 diabetes prevention: Observational multicenter study from Saudi Arabia (2022-09-08)
        • Comparative Risk of Acute Kidney Injury Following Concurrent Administration of Vancomycin with Piperacillin/Tazobactam or Meropenem: A Systematic Review and Meta-Analysis of Observational Studies (2022-04-01)
        • The Association between Self-Care Activities and Depression in Adult Patients with Type 2 Diabetes in Saudi Arabia: A Cross-Sectional Web-Based Survey Study (2024-01-01)
        • Effectiveness and Safety of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes (2024-11-01)
        • Early use of everolimus for neonatal cardiac rhabdomyoma: a pharmacotherapeutic case with pharmacist-led monitoring (2026-05-13)
        • Proton Pump Inhibitor Safety Knowledge and Stress Ulcer Prophylaxis Appropriateness Among Resident Physicians: A Cross-Sectional Study (2026-01-01)
        • Network Meta-analysis of Once Weekly Glucagon-Like Peptide-1 Receptor Agonists: A Focus on Cardiovascular Safety and Mortality (2020-06-01)
        • Network Meta-analysis of Seven Glucagon-Like Peptide-1 Receptor Agonists: A Focus on Cardiovascular Outcome Trials Data (2020-06-01)
        • Glucagon-like Peptide-1 Receptor Agonists and Alcohol Use Outcomes: A Systematic Review of Clinical Evidence (2026-06-19)
        • Budget impact analysis of the introduction of ranibizumab's biosimilar to the Jordanian joint procurement system (vol 14, 1800784, 2026) (2026-06-19)
        • Budget impact analysis of the introduction of ranibizumab's biosimilar to the Jordanian joint procurement system (vol 14, 1800784, 2026) (2026-05-20)
        • Budget impact analysis of the introduction of ranibizumab's biosimilar to the Jordanian joint procurement system (2026-05-07)
        • Trends and patterns of the reported antimicrobial errors to the eastern region's medical centers in Saudi Arabia: A cross-sectional study (2023-10-01)
        • Incidence of Severe Diabetic Ketoacidosis among Children with Type 1 Diabetes Mellitus Prior to and During COVID-Pandemic: A Meta-analysis (2022-06-01)
        • Update in Cardiovascular Safety of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes-A Mixed Treatment Comparison Meta-analysis of Randomized Controlled Trials (2018-07-01)
        • Insights From Practice With Use of Direct Oral Anticoagulants in Transplantation (2018-12-01)
        • Documenting Stage 1 and 2 Meaningful Use criteria: A comparison of clinical pharmacists with other healthcare providers (2018-03-01)
        • Efficacy and safety of direct oral anticoagulants for standard duration thromboprophylaxis in hospitalized medically-ill patients: meta-analysis of randomized controlled trials (2017-12-01)
        • The efficacy of low molecular weight heparin for the prevention of symptomatic venous thromboembolism in patients with lower leg immobilization; a meta-analysis (2017-12-01)
        • Direct oral anticoagulants for extended-duration thromboprophylaxis in hospitalized medically ill patients: are we there yet? (2017-07-01)
        • Novel strategy to increase insulin initiation in the Emergency Department (ED) (2016-12-01)
        • Characteristics of the ideal clinical pharmacy residency candidate: A survey of residency program directors and preceptors in Saudi Arabia (2022-01-24)
        • Research barriers in Saudi pharmacy residency training programs (2023-11-04)
        • Comparative effectiveness of glucagon-like peptide-1 receptor agonists for the management of obesity in adults without diabetes: A network meta-analysis of randomized clinical trials (2022-12-29)
        • Comparative effectiveness of glucagon‐like peptide‐1 receptor agonists for the management of obesity in adults without diabetes: a network meta‐analysis of randomized clinical … (2023-01-01)
        • Parents' hesitancy to vaccinate their 5–11-year-old children against COVID-19 in Saudi Arabia: predictors from the health belief model (2022-01-01)
        • Incidence of diabetic ketoacidosis among pediatrics with type 1 diabetes prior to and during COVID-19 pandemic: a meta-analysis of observational studies (2022-01-01)
        • Indirect comparison of glucagon like peptide-1 receptor agonists regarding cardiovascular safety and mortality in patients with type 2 diabetes mellitus: network meta-analysis (2020-01-01)
        • Drug absorption in bariatric surgery patients: a narrative review (2022-01-01)
        • Network meta-analysis of nine large cardiovascular outcome trials of new antidiabetic drugs (2019-01-01)
        • Update on cardiovascular safety of incretin-based therapy in adults with type 2 diabetes mellitus: a meta-analysis of cardiovascular outcome trials (2019-01-01)
        • Comparative risk of acute kidney injury following concurrent administration of vancomycin with piperacillin/tazobactam or meropenem: a systematic review and meta-analysis of … (2022-01-01)
        • Effectiveness and safety of GLP-1 receptor agonists in patients with type 1 diabetes (2024-01-01)
        • Current situation and barriers to women’s leadership in health care education in Saudi Arabia: A cross-sectional study (2024-01-01)
        • The use of metformin for type 2 diabetes prevention: Observational multicenter study from Saudi Arabia (2022-01-01)
        • The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancer-associated venous thromboembolism: a meta-analysis and review of the guidelines (2021-01-01)
        • Heart failure outcomes and glucagon-like peptide-1 receptor agonists: A systematic review of observational studies (2021-01-01)
        • The impact of pharmacists providing direct patient care as members of interprofessional teams on diabetes management (2017-01-01)
        • Types, trends, and patterns of the reported antimicrobial errors to the eastern region’s medical centers in Saudi Arabia: a cross-sectional study (2023-01-01)
        • Safety and efficacy of dual versus triple antithrombotic therapy (DAT vs TAT) in patients with atrial fibrillation following a PCI: a systematic review and network meta-analysis (2020-01-01)
        • Economic analysis of glucagon like peptide-1 receptor agonists from the Saudi Arabia payer perspective (2022-01-01)
        • Update in cardiovascular safety of glucagon like peptide-1 receptor agonists in patients with type 2 diabetes. A mixed treatment comparison meta-analysis of randomised … (2018-01-01)
        • An update on the effect of sodium glucose cotransporter 2 inhibitors on non-alcoholic fatty liver disease: a systematic review of clinical trials (2024-01-01)
        • The association between self-care activities and depression in adult patients with type 2 diabetes in Saudi Arabia: a cross-sectional web-based survey study (2024-01-01)
        • Real-World Effectiveness and Safety of Apixaban versus Warfarin in patients with acute venous thromboembolism: experience of a large tertiary hospital in Saudi Arabia (2021-01-01)
        • Appropriateness of proton pump inhibitors use in noncritically ill hospitalized children in a tertiary hospital in Saudi Arabia (2023-01-01)
        • Clinical characteristics and outcomes of deep vein thrombosis in relation to location: a retrospective analysis study (2025-01-01)
        • Safety and effectiveness of thromboprophylaxis use in hospitalized elderly medical patients at a Saudi tertiary care center (2021-01-01)
        • Insights from practice with use of direct oral anticoagulants in transplantation (2018-01-01)
        • Safety and Effectiveness of Direct Oral Anticoagulants Versus Warfarin in Patients with Venous Thromboembolism using Real-World Data: A Systematic Review and Meta-Analysis: WA … (2024-01-01)
        • Precipitating factors, complications, and outcomes of diabetic ketoacidosis (DKA) in adults and pediatrics: A descriptive study from two tertiary centers in Riyadh, Saudi Arabia (2025-01-01)
        • DPP4 inhibitors and COVID19 outcomes in patients with type II diabetes: a multicenter retrospective cohort study in Saudi Arabia (2025-01-01)
        • Research barriers in Saudi pharmacy residency training programs (2023-01-01)
        • Corrigendum: Parents' Hesitancy to Vaccinate Their 5–11-Year-Old Children Against COVID-19 in Saudi Arabia: Predictors From the Health Belief Model (2022-01-01)
        • Characteristics of the ideal clinical pharmacy residency candidate: A survey of residency program directors and preceptors in Saudi Arabia (2022-01-01)
        • 445-P: Network Meta-analysis of Seven Glucagon-Like Peptide-1 Receptor Agonists: A Focus on Cardiovascular Outcome Trials Data (2020-01-01)
        • Documenting Stage 1 and 2 Meaningful Use criteria: A comparison of clinical pharmacists with other healthcare providers (2018-01-01)
        • Direct oral anticoagulants for extended-duration thromboprophylaxis in hospitalized medically ill patients: are we there yet? (2017-01-01)
        • Stress ulcer prophylaxis in non-critically ill patients: A cross-sectional survey in Saudi Arabia (2025-01-01)
        • Economic evaluation of brivaracetam in the adjunctive treatment of patients with focal-onset seizure in Jordan (2025-01-01)
        • Association between oral loop diuretics duration before discharge and hospital readmission in acute decompensated heart failure: A multicenter retrospective cohort study (2024-01-01)
        • Metformin use among obese patients with prediabetes in Qassim, Saudi Arabia: An observational study (2023-01-01)
        • 974-P: Network Meta-analysis of Once Weekly Glucagon-Like Peptide-1 Receptor Agonists: A Focus on Cardiovascular Safety and Mortality (2020-01-01)
        • Proton Pump Inhibitor Safety Knowledge and Stress Ulcer Prophylaxis Appropriateness Among Resident Physicians: A Cross-Sectional Study (2026-01-01)
        • Budget impact analysis of the introduction of ranibizumab's biosimilar to the Jordanian joint procurement system (vol 14, 1800784, 2026) (2026-01-01)
        • Glucagon-like Peptide-1 Receptor Agonists and Alcohol Use Outcomes: A Systematic Review of Clinical Evidence (2026-01-01)
        • Early use of everolimus for neonatal cardiac rhabdomyoma: a pharmacotherapeutic case with pharmacist-led monitoring (2026-01-01)
        • Correction: Budget impact analysis of the introduction of ranibizumab's biosimilar to the Jordanian joint procurement system (2026-01-01)
        • Budget impact analysis of the introduction of ranibizumab’s biosimilar to the Jordanian joint procurement system (2026-01-01)
        • EE642 Cost-Effectiveness of Febuxostat 120/80 Mg as a Second-Line After Allopurinol 100/300MG in Gout Patients in Algeria (2024-01-01)
        • Trends and patterns of the reported antimicrobial errors to the eastern region's medical centers in Saudi Arabia: A cross-sectional study (2023-01-01)
        • 1003-P: Incidence of Severe Diabetic Ketoacidosis among Children with Type 1 Diabetes Mellitus Prior to and During COVID-Pandemic: A Meta-analysis (2022-01-01)
        • New Onset Diabetes after Transplant (NODAT) in Hispanic Kidney Transplant Recipients: A Multi-Center Retrospective Study (2020-01-01)
        • Update in Cardiovascular Safety of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes—A Mixed Treatment Comparison Meta-analysis of Randomized … (2018-01-01)
        • Efficacy and safety of direct oral anticoagulants for standard duration thromboprophylaxis in hospitalized medically-ill patients: meta-analysis of randomized controlled trials (2017-01-01)
        • The efficacy of low molecular weight heparin for the prevention of symptomatic venous thromboembolism in patients with lower leg immobilization; a meta-analysis (2017-01-01)
        • Novel strategy to increase insulin initiation in the Emergency Department (ED): 99. (2016-01-01)
        • Comparative Change in HbA1c and Weight Outcomes Between Obese and Non-Obese Adults with Type 2 Diabetes Mellitus Treated With SGLT-2 Inhibitors or GLP-1 Receptor Agonists (2026-01-01)
        • Heart failure outcomes and glucagon-like peptide-1 receptor agonists: A systematic review of observational studies (2021-09-18)
        • Real-World Effectiveness and Safety of Apixaban versus Warfarin in Patients with Acute Venous Thromboembolism: Experience of a Large Tertiary Hospital in Saudi Arabia (2021-01-01)
        • Update on Cardiovascular Safety of Incretin-Based Therapy in Adults With Type 2 Diabetes Mellitus: A Meta-Analysis of Cardiovascular Outcome Trials (2019-10-01)
        • Network meta-analysis of nine large cardiovascular outcome trials of new antidiabetic drugs (2019-06-01)
        • Update in Cardiovascular Safety of Glucagon Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes. A Mixed Treatment Comparison Meta-Analysis of Randomised Controlled Trials (2018-11-01)
        • The impact of pharmacists providing direct patient care as members of interprofessional teams on diabetes management (2017-11-01)

        المواد التدريسية

          ملفات تعريف الارتباط

          هذا الموقع يستخدم ملفات تعريف الارتباط الخاصة لضمان سهولة الاستخدام، وتحسين تجربتك أثناء التصفح، كما يوضح الأحكام والسياسات المتعلقة بخصوصية المستخدم. من خلال الاستمرار في تصفح هذا الموقع، فإنك تقر بقبول استخدام ملفات تعريف الارتباط، وما جاء في سياسة الخصوصية